125 related articles for article (PubMed ID: 3367650)
1. Radioimmunoassay for fluphenazine sulfoxide in human plasma.
Midha KK; Hawes EM; Hubbard JW; McKay G; Rauw G; Sardessai MS; Aravagiri M; Moore MD
J Pharmacol Methods; 1988 Mar; 19(1):63-74. PubMed ID: 3367650
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunoassay for 7-hydroxy metabolite of fluphenazine and its application to plasma level monitoring in schizophrenic patients treated long term with oral and depot fluphenazine.
Aravagiri M; Marder SR; Van Putten T; Hawes EM; McKay G; Midha KK
Ther Drug Monit; 1994 Feb; 16(1):21-9. PubMed ID: 8160250
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic monitoring of steady-state plasma levels of the N4'-oxide metabolite of fluphenazine in chronically treated schizophrenic patients determined by a specific and sensitive radioimmunoassay.
Aravagiri M; Marder SR; Van Putten T; Hawes EM; McKay G; Hubbard JW; Midha KK
Ther Drug Monit; 1990 May; 12(3):268-76. PubMed ID: 2349611
[TBL] [Abstract][Full Text] [Related]
4. Development and application of a specific radioimmunoassay for trifluoperazine N4'-oxide to a kinetic study in humans.
Aravagiri M; Hawes EM; Midha KK
J Pharmacol Exp Ther; 1986 May; 237(2):615-22. PubMed ID: 3701645
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoassay for the 7-hydroxy metabolite of trifluoperazine and its application to a kinetic study in human volunteers.
Aravagiri M; Hawes EM; Midha KK
J Pharm Sci; 1985 Nov; 74(11):1196-202. PubMed ID: 4087181
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoassay for a new phenothiazine derivative and its application.
Rásky K; Losonczy S; Pátfalusi M
Acta Physiol Hung; 1992; 79(1):103-11. PubMed ID: 1363169
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoassay for psychotropic drugs. III: Synthesis and properties of haptens for trifluoperazine and fluphenazine.
Hawes EM; Shetty HU; Cooper JK; Rauw G; McKay G; Midha KK
J Pharm Sci; 1984 Feb; 73(2):247-50. PubMed ID: 6707894
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoassay for the sulfoxide metabolite of trifluoperazine and its application to a kinetic study in humans.
Aravagiri M; Hawes EM; Midha KK
J Pharm Sci; 1984 Oct; 73(10):1383-7. PubMed ID: 6502485
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoassay for trimeprazine in human plasma.
McKay G; Rauw GA; Stonkus MD; Dulos RA; Gedir RG; Hawes EM; Midha KK
J Pharmacol Methods; 1984 Oct; 12(3):203-11. PubMed ID: 6536824
[TBL] [Abstract][Full Text] [Related]
10. Determination of fluphenazine, related phenothiazine drugs and metabolites by combined high-performance liquid chromatography and radioimmunoassay.
Goldstein SA; Van Vunakis H
J Pharmacol Exp Ther; 1981 Apr; 217(1):36-43. PubMed ID: 6110775
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of a radioimmunoassay for phenothiazines and thioxanthenes using an iodinated tracer.
Rowell FJ; Hui SM; Paxton JW
J Immunol Methods; 1979; 31(1-2):159-66. PubMed ID: 512372
[TBL] [Abstract][Full Text] [Related]
12. Radioimmunoassays for phenothiazine drugs and their major metabolites in plasma.
Hawes EM; Aravagiri M; Dulos RA; Rauw GA; Stonkus MD
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):709-14. PubMed ID: 6141613
[TBL] [Abstract][Full Text] [Related]
13. Development of radioimmunoassays for trifluoperazine and their application to metabolic studies of the drug.
Midha KK; Hawes EM; Rauw G; McKay G; Cooper JK; Shetty HU
J Pharmacol Methods; 1983 Jun; 9(4):283-93. PubMed ID: 6621049
[TBL] [Abstract][Full Text] [Related]
14. The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoate.
Midha KK; Hubbard JW; Marder SR; Hawes EM; Van Putten T; McKay G; May PR
Psychopharmacology (Berl); 1987; 93(3):369-73. PubMed ID: 3124166
[TBL] [Abstract][Full Text] [Related]
15. A highly sensitive and specific radioimmunoassay for quantitation of plasma fluphenazine.
Lo ES; Fein M; Hunter C; Suckow RF; Cooper TB
J Pharm Sci; 1988 Mar; 77(3):255-8. PubMed ID: 3373431
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of the N-oxides of phenothiazine antipsychotic agents.
Jaworski TJ; Sardessai MS; Aravagiri M; Lin G; Shi YY; Hawes EM; Hubbard JW; McKay G; Midha KK
J Pharm Sci; 1993 Mar; 82(3):330-3. PubMed ID: 8095544
[TBL] [Abstract][Full Text] [Related]
17. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
[TBL] [Abstract][Full Text] [Related]
18. Clinical perspectives of some neuroleptics through development and application of their assays.
Midha KK; Marder SR; Jaworski TJ; McKay G; Hubbard JW; Hawes EM; Van Putten T; Wirshing WC; Aravagiri M
Ther Drug Monit; 1993 Jun; 15(3):179-89. PubMed ID: 8101398
[TBL] [Abstract][Full Text] [Related]
19. Development and application of a specific and sensitive radioimmunoassay for trihexyphenidyl to a pharmacokinetic study in humans.
He H; McKay G; Wirshing B; Midha KK
J Pharm Sci; 1995 May; 84(5):561-7. PubMed ID: 7658345
[TBL] [Abstract][Full Text] [Related]
20. Fluphenazine determination in human plasma by a sensitive gas chromatographic method using nitrogen detector.
Javaid JI; Dekirmenjian H; Liskevych U; Lin RL; Davis JM
J Chromatogr Sci; 1981 Sep; 19(9):439-43. PubMed ID: 7298790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]